News | July 11, 2022
Glenmark Pharma launches Minym Gel for acne treatment
MINYM can be safely used by patients above 9 years of age.
MINYM can be safely used by patients above 9 years of age.
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
A total of five observations for Goa and 17 for Monroe
According to IQVIA sales data for the 12-month period ending March 2022, the Zytiga tablets, 500 mg market achieved annual sales of approximately US $ 260.2 million
Subscribe To Our Newsletter & Stay Updated
